首页 | 官方网站   微博 | 高级检索  
     

卡铂加顺铂治疗晚期非小细胞肺癌的疗效观察
引用本文:周定.卡铂加顺铂治疗晚期非小细胞肺癌的疗效观察[J].癌症,1994,13(3):245-246.
作者姓名:周定
作者单位:湖南省肿瘤医院
摘    要:全组共19例经病理学证实的晚期非小细胞肺癌。应用卡铂300mg/m^2第1天静脉输入,顺铂20mg/m^2第1-3天静脉输入,每3周重复一次。19例均可评定疗效与毒性。8例(42.1%)获部分缓解,无完全缓解病例,其中未接受过化疗的15例,7例(46.7%)获部分缓解。毒副反应主要为骨髓抑制。消化道反应等。

关 键 词:卡铂  顺铂  肺肿瘤  小细胞癌

THERAPEUTIC RESULT OF PHASE II CLINICAL TRIAL OF CISPLATIN PLUS CARBOPLATIN THERAPY IN NON-SMALL CELL LUNG CANCER(NSCLC)
ZHoU Ding.THERAPEUTIC RESULT OF PHASE II CLINICAL TRIAL OF CISPLATIN PLUS CARBOPLATIN THERAPY IN NON-SMALL CELL LUNG CANCER(NSCLC)[J].Chinese Journal of Cancer,1994,13(3):245-246.
Authors:ZHoU Ding
Abstract:A phase II pilot study of carboplatin 300mg/m2 followed by cisplatin60mg/m2 was initiated in 19 patients with NSCLC. Interim analysis showed that 8 patentshave had at least a partial response to cisplatin/carboplatin, with a response rate of 42.1%The response rate in previously untreated patients was 46. 7%,while in previously treatedpatients was 25%. No serio us adverse effects were oberved.Futher studies with the cis-platin/carboplatin combination in NSCIC are warranted.
Keywords:Non-small cell cancer  Cisplatin Carbopla tin  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号